218 related articles for article (PubMed ID: 10775108)
1. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes.
Corper AL; Stratmann T; Apostolopoulos V; Scott CA; Garcia KC; Kang AS; Wilson IA; Teyton L
Science; 2000 Apr; 288(5465):505-11. PubMed ID: 10775108
[TBL] [Abstract][Full Text] [Related]
2. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder.
Stratmann T; Apostolopoulos V; Mallet-Designe V; Corper AL; Scott CA; Wilson IA; Kang AS; Teyton L
J Immunol; 2000 Sep; 165(6):3214-25. PubMed ID: 10975837
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7.
Reizis B; Eisenstein M; Bocková J; Könen-Waisman S; Mor F; Elias D; Cohen IR
Int Immunol; 1997 Jan; 9(1):43-51. PubMed ID: 9043946
[TBL] [Abstract][Full Text] [Related]
4. The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library.
Gregori S; Bono E; Gallazzi F; Hammer J; Harrison LC; Adorini L
Int Immunol; 2000 Apr; 12(4):493-503. PubMed ID: 10744651
[TBL] [Abstract][Full Text] [Related]
5. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.
Quarsten H; Paulsen G; Johansen BH; Thorpe CJ; Holm A; Buus S; Sollid LM
Int Immunol; 1998 Aug; 10(8):1229-36. PubMed ID: 9723710
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.
Latek RR; Suri A; Petzold SJ; Nelson CA; Kanagawa O; Unanue ER; Fremont DH
Immunity; 2000 Jun; 12(6):699-710. PubMed ID: 10894169
[TBL] [Abstract][Full Text] [Related]
7. The MHC class II molecule I-Ag7 exists in alternate conformations that are peptide dependent.
Arneson LS; Peterson M; Sant AJ
J Immunol; 2000 Aug; 165(4):2059-67. PubMed ID: 10925290
[TBL] [Abstract][Full Text] [Related]
8. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
9. The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection.
Suri A; Unanue ER
Adv Immunol; 2005; 88():235-65. PubMed ID: 16227092
[TBL] [Abstract][Full Text] [Related]
10. Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus.
Quartey-Papafio R; Lund T; Chandler P; Picard J; Ozegbe P; Day S; Hutchings PR; O'Reilly L; Kioussis D; Simpson E
J Immunol; 1995 May; 154(10):5567-75. PubMed ID: 7730655
[TBL] [Abstract][Full Text] [Related]
11. The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity.
Yoshida K; Corper AL; Herro R; Jabri B; Wilson IA; Teyton L
J Clin Invest; 2010 May; 120(5):1578-90. PubMed ID: 20407212
[TBL] [Abstract][Full Text] [Related]
12. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
13. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER
J Immunol; 1996 Jan; 156(2):450-8. PubMed ID: 8543793
[TBL] [Abstract][Full Text] [Related]
14. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes.
Yu B; Gauthier L; Hausmann DH; Wucherpfennig KW
Eur J Immunol; 2000 Sep; 30(9):2497-506. PubMed ID: 11009082
[TBL] [Abstract][Full Text] [Related]
15. Importance of GAD65 peptides and I-Ag7 in the development of insulitis in nonobese diabetic mice.
Ogino T; Sato K; Miyokawa N; Kimura S; Katagiri M
Immunogenetics; 2000 Jun; 51(7):538-45. PubMed ID: 10912505
[TBL] [Abstract][Full Text] [Related]
16. pH-dependent peptide binding properties of the type I diabetes-associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH.
Hausmann DH; Yu B; Hausmann S; Wucherpfennig KW
J Exp Med; 1999 Jun; 189(11):1723-34. PubMed ID: 10359576
[TBL] [Abstract][Full Text] [Related]
17. The role of I-Ag7 beta chain in peptide binding and antigen recognition by T cells.
Kanagawa O; Shimizu J; Unanue ER
Int Immunol; 1997 Oct; 9(10):1523-6. PubMed ID: 9352357
[TBL] [Abstract][Full Text] [Related]
18. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.
Peterson M; Sant AJ
J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif.
Zhu Y; Rudensky AY; Corper AL; Teyton L; Wilson IA
J Mol Biol; 2003 Feb; 326(4):1157-74. PubMed ID: 12589760
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the unique class II MHC molecule, I-Ag7, which is also protective against the development of autoimmune diabetes.
Xu XJ; Gearon C; Stevens E; Vergani D; Baum H; Peakman M
Diabetologia; 1999 May; 42(5):560-5. PubMed ID: 10333048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
